Seroquel XR in the long term treatment of schizophrenia - SereNIS
Study identifier:NIS-NHU-SER-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Seroquel XR in the long term treatment of schizophrenia focus on affective symptoms
Medical condition
relapse in schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1606
Study type
Observational
Age
18 Years - 70 Years
Date
Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Schizophrenic outpatients between 18 & 70 years of age | - |
Contacts
Investigators
Principal Investigator
Attila Nemeth
National Psychiatric Centre
